Wimmer Associates 1’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $433K | Hold |
3,110
| – | – | 0.21% | 77 |
|
|
2025
Q4 | $382K | Hold |
3,110
| – | – | 0.18% | 82 |
|
|
2025
Q3 | $345K | Hold |
3,110
| – | – | 0.17% | 87 |
|
|
2025
Q2 | $345K | Hold |
3,110
| – | – | 0.18% | 88 |
|
|
2025
Q1 | $315K | Hold |
3,110
| – | – | 0.17% | 89 |
|
|
2024
Q4 | $287K | Hold |
3,110
| – | – | 0.14% | 96 |
|
|
2024
Q3 | $261K | Hold |
3,110
| – | – | 0.13% | 104 |
|
|
2024
Q2 | $213K | Hold |
3,110
| – | – | 0.11% | 106 |
|
|
2024
Q1 | $228K | Hold |
3,110
| – | – | 0.12% | 105 |
|
|
2023
Q4 | $252K | Hold |
3,110
| – | – | 0.14% | 102 |
|
|
2023
Q3 | $233K | Hold |
3,110
| – | – | 0.15% | 102 |
|
|
2023
Q2 | $240K | Hold |
3,110
| – | – | 0.14% | 104 |
|
|
2023
Q1 | $244K | Hold |
3,110
| – | – | 0.16% | 103 |
|
|
2022
Q4 | $267K | Sell |
3,110
-75
| -2% | -$5.94K | 0.18% | 96 |
|
|
2022
Q3 | $250K | Buy |
+3,185
| New | +$201K | 0.17% | 97 |
|
|
2022
Q1 | – | Sell |
-3,365
| Closed | -$244K | – | 119 |
|
|
2021
Q4 | $244K | Sell |
3,365
-30
| -0.9% | -$2.07K | 0.13% | 110 |
|
|
2021
Q3 | $237K | Sell |
3,395
-85
| -2% | -$5.97K | 0.14% | 113 |
|
|
2021
Q2 | $240K | Hold |
3,480
| – | – | 0.14% | 110 |
|
|
2021
Q1 | $225K | Sell |
3,480
-735
| -17% | -$47.4K | 0.12% | 108 |
|
|
2020
Q4 | $246K | Buy |
4,215
+65
| +2% | +$3.92K | 0.15% | 98 |
|
|
2020
Q3 | $262K | Buy |
4,150
+215
| +5% | +$14.9K | 0.18% | 90 |
|
|
2020
Q2 | $270K | Buy |
3,935
+725
| +23% | +$55.6K | 0.21% | 90 |
|
|
2020
Q1 | $240K | Sell |
3,210
-235
| -7% | -$16.2K | 0.22% | 90 |
|
|
2019
Q4 | $224K | Hold |
3,445
| – | – | 0.18% | 99 |
|
|
2019
Q3 | $218K | Sell |
3,445
-150
| -4% | -$9.8K | 0.19% | 95 |
|
|
2019
Q2 | $243K | Hold |
3,595
| – | – | 0.21% | 95 |
|
|
2019
Q1 | $234K | Hold |
3,595
| – | – | 0.21% | 96 |
|
|
2018
Q4 | $225K | Buy |
3,595
+75
| +2% | +$5.24K | 0.22% | 96 |
|
|
2018
Q3 | $272K | Sell |
3,520
-402
| -10% | -$30.4K | 0.23% | 94 |
|
|
2018
Q2 | $278K | Sell |
3,922
-68
| -2% | -$4.8K | 0.25% | 92 |
|
|
2018
Q1 | $301K | Buy |
3,990
+136
| +4% | +$10.8K | 0.27% | 93 |
|
|
2017
Q4 | $276K | Hold |
3,854
| – | – | 0.25% | 99 |
|
|
2017
Q3 | $312K | Hold |
3,854
| – | – | 0.29% | 91 |
|
|
2017
Q2 | $273K | Sell |
3,854
-656
| -15% | -$43.7K | 0.25% | 98 |
|
|
2017
Q1 | $306K | Sell |
4,510
-7,089
| -61% | -$498K | 0.29% | 92 |
|
|
2016
Q4 | $831K | Sell |
11,599
-2,129
| -16% | -$158K | 0.77% | 48 |
|
|
2016
Q3 | $1.09M | Sell |
13,728
-269
| -2% | -$21.9K | 0.98% | 40 |
|
|
2016
Q2 | $1.17M | Buy |
13,997
+112
| +0.8% | +$9.94K | 1.04% | 36 |
|
|
2016
Q1 | $1.28M | Buy |
13,885
+1,350
| +11% | +$122K | 1.17% | 32 |
|
|
2015
Q4 | $1.27M | Buy |
+12,535
| New | +$1.3M | 1.33% | 29 |
|
Other funds holding GILD
VCM
VPM
Wimmer Associates 1's GILD Position: Q1 2026 in Review
Wimmer Associates 1 held its Gilead Sciences (GILD) position steady in Q1 2026 at 3,110 shares worth $433K. The position accounts for 0.21% of the portfolio, ranked #77.
Wimmer Associates 1 first reported a position in GILD in Q4 2015 and has held it in 40 quarters since. The position peaked at $1.28M in Q1 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Wimmer Associates 1 held 3,110 shares of Gilead Sciences worth $433K as of Q1 2026.
- Wimmer Associates 1 left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up 0.21% of Wimmer Associates 1's portfolio in Q1 2026, its #77 holding.
- Wimmer Associates 1 first reported a position in Gilead Sciences in Q4 2015 and has held it in 40 quarters since.
- Wimmer Associates 1's Gilead Sciences position peaked at $1.28M in Q1 2016.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Wimmer Associates 1's 13F filing for Q1 2026, filed 15 May 2026.